<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
<title>Fundmetricflow</title>
<link>https://fundmetricflow.com</link>
<description>Fundmetricflow — latest news</description>
<atom:link href="https://fundmetricflow.com/rss.xml" rel="self" type="application/rss+xml" />
<language>en-us</language>
<item>
<title>SEC Chair Atkins Moves to Eliminate Shareholder Proposal Rule</title>
<link>https://fundmetricflow.com/article/sec-chair-atkins-moves-to-eliminate-shareholder-proposal-rule</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/sec-chair-atkins-moves-to-eliminate-shareholder-proposal-rule</guid>
<pubDate>2026-09-19T02:02:49.102003+00:00</pubDate>
<description>The SEC is seeking to scrap a rule widely used by activist investors. Chair Paul Atkins calls it a top regulatory priority.</description>
<category>policy</category>
</item>
<item>
<title>Howard Buffett to Succeed Warren as Berkshire Hathaway Chairman</title>
<link>https://fundmetricflow.com/article/howard-buffett-to-succeed-warren-as-berkshire-hathaway-chairman</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/howard-buffett-to-succeed-warren-as-berkshire-hathaway-chairman</guid>
<pubDate>2026-09-19T02:02:44.629593+00:00</pubDate>
<description>Howard Buffett, 71, is set to take the chairman role at Berkshire Hathaway, stepping into his father Warren's seat without assuming operational control.</description>
<category>business</category>
</item>
<item>
<title>Food Companies Reshape Products as GLP-1 Drug Use Grows</title>
<link>https://fundmetricflow.com/article/food-companies-reshape-products-as-glp-1-drug-use-grows</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/food-companies-reshape-products-as-glp-1-drug-use-grows</guid>
<pubDate>2026-09-19T02:02:42.040715+00:00</pubDate>
<description>Weight-loss medications like Ozempic are curbing appetites and cutting consumer spending on food, pushing businesses to adapt.</description>
<category>business</category>
</item>
<item>
<title>Middle East Conflict Drives Bond Yields Higher, Pressuring Fed</title>
<link>https://fundmetricflow.com/article/middle-east-conflict-drives-bond-yields-higher-pressuring-fed</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/middle-east-conflict-drives-bond-yields-higher-pressuring-fed</guid>
<pubDate>2026-09-19T02:02:42.040113+00:00</pubDate>
<description>Rising tensions tied to the Iran conflict are rattling global markets and pushing interest rates upward, complicating the Federal Reserve's policy path.</description>
<category>markets</category>
</item>
<item>
<title>Redwood Trust CEO Christopher Abate Buys $383,900 in Stock</title>
<link>https://fundmetricflow.com/article/redwood-trust-ceo-christopher-abate-buys-383-900-in-stock</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/redwood-trust-ceo-christopher-abate-buys-383-900-in-stock</guid>
<pubDate>2026-09-19T02:02:39.014454+00:00</pubDate>
<description>Redwood Trust's top executive made a notable open-market purchase of company shares, signaling insider confidence in the mortgage REIT.</description>
<category>markets</category>
</item>
<item>
<title>Trump Touts Medicaid Drug Price Program With State Buy-In</title>
<link>https://fundmetricflow.com/article/trump-touts-medicaid-drug-price-program-with-state-buy-in</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/trump-touts-medicaid-drug-price-program-with-state-buy-in</guid>
<pubDate>2026-09-19T02:02:37.939633+00:00</pubDate>
<description>President Trump promoted a program aligning Medicaid drug prices with those in other wealthy nations, claiming full participation from all states.</description>
<category>policy</category>
</item>
<item>
<title>Tempus AI Data Chief Ryan Fukushima Sells $49,000 in Stock</title>
<link>https://fundmetricflow.com/article/tempus-ai-data-chief-ryan-fukushima-sells-49-000-in-stock</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/tempus-ai-data-chief-ryan-fukushima-sells-49-000-in-stock</guid>
<pubDate>2026-09-19T02:02:25.898984+00:00</pubDate>
<description>Tempus AI's data CEO Ryan Fukushima disclosed an insider stock sale valued at approximately $49,000, according to regulatory filings.</description>
<category>markets</category>
</item>
<item>
<title>Tempus AI Chief Legal Officer Sells $221,325 in Company Stock</title>
<link>https://fundmetricflow.com/article/tempus-ai-chief-legal-officer-sells-221-325-in-company-stock</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/tempus-ai-chief-legal-officer-sells-221-325-in-company-stock</guid>
<pubDate>2026-09-19T02:02:25.010983+00:00</pubDate>
<description>Tempus AI's EVP and chief legal officer disclosed a stock sale totaling $221,325, according to a regulatory filing.</description>
<category>markets</category>
</item>
<item>
<title>Oracle Data Center Debt Faces Pressure Over Project Concerns</title>
<link>https://fundmetricflow.com/article/oracle-data-center-debt-faces-pressure-over-project-concerns</link>
<guid isPermaLink="true">https://fundmetricflow.com/article/oracle-data-center-debt-faces-pressure-over-project-concerns</guid>
<pubDate>2026-09-19T02:02:24.791131+00:00</pubDate>
<description>Oracle's data center financing is under scrutiny as concerns emerge about underlying project viability, according to the Financial Times.</description>
<category>markets</category>
</item>
</channel></rss>